(ENTG) Entegris - Ratings and Ratios
Deposition Materials, Chemical Slurries, Specialty Gases, Filtration Systems, Purification
ENTG EPS (Earnings per Share)
ENTG Revenue
| Risk via 10d forecast | |
|---|---|
| Volatility | 54.2% |
| Value at Risk 5%th | 86.5% |
| Relative Tail Risk | -3.04% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.22 |
| Alpha | -47.65 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.546 |
| Beta | 2.287 |
| Beta Downside | 2.422 |
| Drawdowns 3y | |
|---|---|
| Max DD | 56.93% |
| Mean DD | 20.06% |
| Median DD | 16.62% |
Description: ENTG Entegris October 31, 2025
Entegris, Inc. (NASDAQ: ENTG) supplies advanced materials and contamination-control solutions to the semiconductor and broader high-technology sectors across North America, Asia, and Europe, operating through two primary segments: Materials Solutions (MS) and Advanced Purity Solutions (APS).
The MS segment delivers specialty chemicals and consumables-including chemical vapor deposition (CVD) and atomic layer deposition (ALD) precursors, chemical-mechanical planarization (CMP) slurries and pads, ion-implantation gases, and formulated etch/clean materials-supporting wafer fabrication and advanced packaging processes.
APS focuses on filtration, purification, and contamination-control hardware and services that protect critical process equipment and downstream products, serving not only semiconductor fabs but also equipment makers, gas/chemical producers, and wafer growers.
Key customers span logic and memory chipmakers, semiconductor equipment manufacturers, flat-panel display and hard-disk drive suppliers, as well as adjacent markets such as solar, life-science, aerospace, and biomedical device manufacturers.
Recent financial data (FY 2023) show revenue of roughly $2.1 billion, with an operating margin near 13 % and a year-over-year sales increase of about 8 %, driven largely by rising demand for AI-related chips and advanced packaging. The company’s exposure to the semiconductor cycle is moderated by its diversified end-markets and its strategic focus on high-purity filtration, a segment projected to grow at a compound annual rate of 6-8 % through 2028 as fab capacity expands worldwide.
Given Entegris’s position in a supply-chain-critical niche and its solid cash-flow generation, a deeper, data-driven valuation of ENTG can be explored on ValueRay for investors seeking quantitative insight.
ENTG Stock Overview
| Market Cap in USD | 13,139m |
| Sub-Industry | Semiconductor Materials & Equipment |
| IPO / Inception | 2000-07-11 |
| Return 12m vs S&P 500 | -32.0% |
| Analyst Rating | 4.44 of 5 |
ENTG Dividends
| Dividend Yield | 0.49% |
| Yield on Cost 5y | 0.46% |
| Yield CAGR 5y | 5.74% |
| Payout Consistency | 98.1% |
| Payout Ratio | 13.8% |
ENTG Growth Ratios
| CAGR 3y | 4.68% |
| CAGR/Max DD Calmar Ratio | 0.08 |
| CAGR/Mean DD Pain Ratio | 0.23 |
| Current Volume | 2648.9k |
| Average Volume | 2289.7k |
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income (288.4m TTM) > 0 and > 6% of Revenue (6% = 193.4m TTM) |
| FCFTA 0.06 (>2.0%) and ΔFCFTA 2.83pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 37.37% (prev 35.22%; Δ 2.15pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.08 (>3.0%) and CFO 679.5m > Net Income 288.4m (YES >=105%, WARN >=100%) |
| Net Debt (-334.5m) to EBITDA (897.8m) ratio: -0.37 <= 3.0 (WARN <= 3.5) |
| Current Ratio 3.44 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (152.3m) change vs 12m ago 0.25% (target <= -2.0% for YES) |
| Gross Margin 44.89% (prev 45.08%; Δ -0.19pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 38.19% (prev 37.81%; Δ 0.38pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 2.58 (EBITDA TTM 897.8m / Interest Expense TTM 199.5m) >= 6 (WARN >= 3) |
Altman Z'' 2.28
| (A) 0.14 = (Total Current Assets 1.70b - Total Current Liabilities 492.7m) / Total Assets 8.40b |
| (B) 0.18 = Retained Earnings (Balance) 1.52b / Total Assets 8.40b |
| (C) 0.06 = EBIT TTM 514.0m / Avg Total Assets 8.44b |
| (D) 0.32 = Book Value of Equity 1.46b / Total Liabilities 4.51b |
| Total Rating: 2.28 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 50.49
| 1. Piotroski 5.0pt = 0.0 |
| 2. FCF Yield 3.95% = 1.97 |
| 3. FCF Margin 15.68% = 3.92 |
| 4. Debt/Equity 0.02 = 2.50 |
| 5. Debt/Ebitda -0.37 = 2.50 |
| 6. ROIC - WACC (= -4.27)% = -5.34 |
| 7. RoE 7.62% = 0.64 |
| 8. Rev. Trend -78.65% = -5.90 |
| 9. EPS Trend 3.94% = 0.20 |
What is the price of ENTG shares?
Over the past week, the price has changed by -5.41%, over one month by -11.71%, over three months by +1.59% and over the past year by -22.54%.
Is Entegris a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of ENTG is around 69.22 USD . This means that ENTG is currently overvalued and has a potential downside of -14.61%.
Is ENTG a buy, sell or hold?
- Strong Buy: 5
- Buy: 3
- Hold: 1
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the ENTG price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 100.5 | 24% |
| Analysts Target Price | 100.5 | 24% |
| ValueRay Target Price | 78.8 | -2.8% |
ENTG Fundamental Data Overview November 11, 2025
P/E Trailing = 45.6158
P/E Forward = 27.1739
P/S = 4.0773
P/B = 3.8479
P/EG = 1.4942
Beta = 1.307
Revenue TTM = 3.22b USD
EBIT TTM = 514.0m USD
EBITDA TTM = 897.8m USD
Long Term Debt = 3.98b USD (from longTermDebt, last fiscal year)
Short Term Debt = 50.0m USD (from shortTermDebt, two quarters ago)
Debt = 65.3m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -334.5m USD (from netDebt column, last quarter)
Enterprise Value = 12.80b USD (13.14b + Debt 65.3m - CCE 399.8m)
Interest Coverage Ratio = 2.58 (Ebit TTM 514.0m / Interest Expense TTM 199.5m)
FCF Yield = 3.95% (FCF TTM 505.3m / Enterprise Value 12.80b)
FCF Margin = 15.68% (FCF TTM 505.3m / Revenue TTM 3.22b)
Net Margin = 8.95% (Net Income TTM 288.4m / Revenue TTM 3.22b)
Gross Margin = 44.89% ((Revenue TTM 3.22b - Cost of Revenue TTM 1.78b) / Revenue TTM)
Gross Margin QoQ = 43.53% (prev 44.36%)
Tobins Q-Ratio = 1.52 (Enterprise Value 12.80b / Total Assets 8.40b)
Interest Expense / Debt = 70.60% (Interest Expense 46.1m / Debt 65.3m)
Taxrate = 2.07% (1.50m / 72.3m)
NOPAT = 503.3m (EBIT 514.0m * (1 - 2.07%))
Current Ratio = 3.44 (Total Current Assets 1.70b / Total Current Liabilities 492.7m)
Debt / Equity = 0.02 (Debt 65.3m / totalStockholderEquity, last quarter 3.89b)
Debt / EBITDA = -0.37 (Net Debt -334.5m / EBITDA 897.8m)
Debt / FCF = -0.66 (Net Debt -334.5m / FCF TTM 505.3m)
Total Stockholder Equity = 3.79b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.43% (Net Income 288.4m / Total Assets 8.40b)
RoE = 7.62% (Net Income TTM 288.4m / Total Stockholder Equity 3.79b)
RoCE = 6.62% (EBIT 514.0m / Capital Employed (Equity 3.79b + L.T.Debt 3.98b))
RoIC = 6.51% (NOPAT 503.3m / Invested Capital 7.73b)
WACC = 10.78% (E(13.14b)/V(13.20b) * Re(10.83%) + (debt cost/tax rate unavailable))
Discount Rate = 10.83% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.32%
[DCF Debug] Terminal Value 59.02% ; FCFE base≈411.0m ; Y1≈269.8m ; Y5≈123.4m
Fair Price DCF = 10.85 (DCF Value 1.64b / Shares Outstanding 151.6m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: 3.94 | EPS CAGR: -5.04% | SUE: 0.0 | # QB: 0
Revenue Correlation: -78.65 | Revenue CAGR: -5.61% | SUE: 0.14 | # QB: 0
Additional Sources for ENTG Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle